Cargando…
Drug therapy for heart failure in older patients—what do they want?
Chronic heart failure (CHF) is predominantly seen in older patients, and therefore real life medicine often requires the extrapolation of findings from trials conducted in much younger populations. Prescribing patterns and potential benefits in the elderly are heavily influenced by polypharmacy and...
Autores principales: | Zachariah, Donah, Taylor, Jacqueline, Rowell, Nigel, Spooner, Clare, Kalra, Paul R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Science Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394332/ https://www.ncbi.nlm.nih.gov/pubmed/25870620 http://dx.doi.org/10.11909/j.issn.1671-5411.2015.02.011 |
Ejemplares similares
-
Ivabradine tolerability in heart failure
por: Birkhoelzer, Sarah, et al.
Publicado: (2018) -
Do What You Want
por: Bate, Nicholas
Publicado: (2012) -
What Do We Want? INHIBITION. When Do We Want it? NOW
por: Maguire, Jamie L.
Publicado: (2019) -
What do cells actually want?
por: Feist, Adam M., et al.
Publicado: (2016) -
What Do General Practitioners Want?
Publicado: (1897)